<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01390662</url>
  </required_header>
  <id_info>
    <org_study_id>26992</org_study_id>
    <secondary_id>2010-023531-42</secondary_id>
    <nct_id>NCT01390662</nct_id>
  </id_info>
  <brief_title>Can Vitamin D3 Supplementation Affect Treatment Outcomes in Patients With Depression</brief_title>
  <acronym>D3-vit-dep</acronym>
  <official_title>Phase 4 Study of Vitamin D3 Supplementation for Outcomes in Patients With Unipolar Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Syddanmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Syddanmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether patients with depression should be
      offered vitamin D supplements, or it has no significance in relation to treatment outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D3 is produced in the skin after exposure to ultraviolet B light from the sun.
      Vitamin D3 is metabolised sequential in the liver into 25-hydroxy-vitamin D [25(OH)D], which
      is the storage form of vitamin D in the body, and then in the kidney into the steroid
      hormone, 1a,25-dihydroxyvitamin 1a,25-dihydroxyvitamin D [1,25(OH)2D].

      At higher latitudes ultraviolet B light is stopped by the atmosphere during winter season.
      Half of Danes have low levels of [25(OH)D] in the blood and especially in the early spring
      months the levels of [25(OH)D] are low. In addition, Vitamin D3 is absorbed through the gut
      from vitamin D-rich food sources. But several studies show that it is not possible through a
      recommended diet, which consists of 300 g of fish per week to consume adequate amounts of
      vitamin D3.

      New research suggests link between vitamin D3 and brain function.In the Central Nervous
      System (CNS) there are specific nuclear receptors for 1,25(OH)2D (VDR) and the enzymes
      necessary for the hydroxylation of 25(OH)D to 1,25(OH)2D are also present in CNS.

      In clinical studies, low serum levels of 25(OH)D, have been associated with reduced cognitive
      function, anxiety and depression.

      The objective of this randomized clinical trial is to investigate whether patients with
      depression should be offered vitamin D3 supplements, or it has no significance in relation to
      treatment outcomes.

      The study is carried out in Mental Health Services in the Region of Southern Denmark for 24
      weeks and offered to patients being treated for depression (treatment as usual) plus 70μg
      vitamin D3 or placebo.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton 17 item scale (Hamilton-17)</measure>
    <time_frame>24 weeks</time_frame>
    <description>Change from baseline in Hamilton-17 at week 24</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>WHO-Five Well-being Index (WHO-5)</measure>
    <time_frame>24 weeks</time_frame>
    <description>Change from baseline in WHO-five at week 24</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Vitamin D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>one tablet of vitamin D3 (70µg) per day for 24 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>one tablet of sugar pill per day for 24 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>one tablet of vitamin D3 70 µg pr. day, for 24 weeks.</description>
    <arm_group_label>Vitamin D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>one tablet of sugar pill pr. day, for 24 weeks.</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  clinical diagnosis unipolar depression

        Exclusion Criteria:

          -  clinical diagnosis sarcoidoses

          -  tuberculosis

          -  bipolar affective disorder

          -  schizophrenia

          -  hypercalcemia

          -  hyperphosphatemia

          -  electroconvulsive treatment for the last 6 months

          -  primary diagnosis addiction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Connie T Nielsen, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Mental Health Services Esbjerg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erik Dahl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mental Health Services Svendborg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tomas toft, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mental Health Services Odense</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Connie T Nielsen, PhD</last_name>
    <phone>+4579182947</phone>
    <email>connie.thuroee.nielsen@psyk.regionsyddanmark.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne-Lene Kjeldmann</last_name>
    <phone>+4579182947</phone>
    <email>anne-lene.kjeldmann@psyk.regionsyddanmark.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mental Health Services Esbjerg</name>
      <address>
        <city>Esbjerg</city>
        <zip>DK-6715</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Connie T Nielsen, PhD</last_name>
      <phone>+4579182947</phone>
      <email>connie.thuroee.nielsen@psyk.regionsyddanmark.dk</email>
    </contact>
    <investigator>
      <last_name>Connie T Nielsen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Services, Odense</name>
      <address>
        <city>Odense</city>
        <zip>Dk-5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomas Toft, Ph.D</last_name>
      <phone>+4565413300</phone>
      <email>tomas.toft@psyk.regionsyddanmark.dk</email>
    </contact>
    <investigator>
      <last_name>Tomas Toft, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Services Svendborg</name>
      <address>
        <city>Svendborg</city>
        <zip>DK-5700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Dahl, MD</last_name>
      <phone>63201051</phone>
      <email>Erik.dahl@psyk.regionsyddanmark.dk</email>
    </contact>
    <investigator>
      <last_name>Erik Dahl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2011</study_first_submitted>
  <study_first_submitted_qc>July 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2011</study_first_posted>
  <last_update_submitted>March 27, 2012</last_update_submitted>
  <last_update_submitted_qc>March 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2012</last_update_posted>
  <responsible_party>
    <name_title>Connie Thuroee Nielsen, consultant,PhD</name_title>
    <organization>Mental Health Services Esbjerg</organization>
  </responsible_party>
  <keyword>serum 25-hydroxyvitamin d,vitamin D supplement, depression,</keyword>
  <keyword>parathyroid hormone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

